HDV+HBV hepatitis reactivation due to immunossuppressive therapy for hematological malignancies – an increasingly complex challenge

Detalles Bibliográficos
Autores principales: Molagic, Violeta, Mihăilescu, Raluca, Popescu, Cristina, Tilişcan, Cătălin, Rădulescu, Mihaela, Năstase, Raluca, Moroti, Ruxandra, Poghirc, Viorica, Aramă, Victoria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Oral Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3882657/
http://dx.doi.org/10.1186/1471-2334-13-S1-O24
_version_ 1782298376125022208
author Molagic, Violeta
Mihăilescu, Raluca
Popescu, Cristina
Tilişcan, Cătălin
Rădulescu, Mihaela
Năstase, Raluca
Moroti, Ruxandra
Poghirc, Viorica
Aramă, Victoria
author_facet Molagic, Violeta
Mihăilescu, Raluca
Popescu, Cristina
Tilişcan, Cătălin
Rădulescu, Mihaela
Năstase, Raluca
Moroti, Ruxandra
Poghirc, Viorica
Aramă, Victoria
author_sort Molagic, Violeta
collection PubMed
description
format Online
Article
Text
id pubmed-3882657
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38826572014-01-09 HDV+HBV hepatitis reactivation due to immunossuppressive therapy for hematological malignancies – an increasingly complex challenge Molagic, Violeta Mihăilescu, Raluca Popescu, Cristina Tilişcan, Cătălin Rădulescu, Mihaela Năstase, Raluca Moroti, Ruxandra Poghirc, Viorica Aramă, Victoria BMC Infect Dis Oral Presentation BioMed Central 2013-12-16 /pmc/articles/PMC3882657/ http://dx.doi.org/10.1186/1471-2334-13-S1-O24 Text en Copyright © 2013 Molagic et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Oral Presentation
Molagic, Violeta
Mihăilescu, Raluca
Popescu, Cristina
Tilişcan, Cătălin
Rădulescu, Mihaela
Năstase, Raluca
Moroti, Ruxandra
Poghirc, Viorica
Aramă, Victoria
HDV+HBV hepatitis reactivation due to immunossuppressive therapy for hematological malignancies – an increasingly complex challenge
title HDV+HBV hepatitis reactivation due to immunossuppressive therapy for hematological malignancies – an increasingly complex challenge
title_full HDV+HBV hepatitis reactivation due to immunossuppressive therapy for hematological malignancies – an increasingly complex challenge
title_fullStr HDV+HBV hepatitis reactivation due to immunossuppressive therapy for hematological malignancies – an increasingly complex challenge
title_full_unstemmed HDV+HBV hepatitis reactivation due to immunossuppressive therapy for hematological malignancies – an increasingly complex challenge
title_short HDV+HBV hepatitis reactivation due to immunossuppressive therapy for hematological malignancies – an increasingly complex challenge
title_sort hdv+hbv hepatitis reactivation due to immunossuppressive therapy for hematological malignancies – an increasingly complex challenge
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3882657/
http://dx.doi.org/10.1186/1471-2334-13-S1-O24
work_keys_str_mv AT molagicvioleta hdvhbvhepatitisreactivationduetoimmunossuppressivetherapyforhematologicalmalignanciesanincreasinglycomplexchallenge
AT mihailescuraluca hdvhbvhepatitisreactivationduetoimmunossuppressivetherapyforhematologicalmalignanciesanincreasinglycomplexchallenge
AT popescucristina hdvhbvhepatitisreactivationduetoimmunossuppressivetherapyforhematologicalmalignanciesanincreasinglycomplexchallenge
AT tiliscancatalin hdvhbvhepatitisreactivationduetoimmunossuppressivetherapyforhematologicalmalignanciesanincreasinglycomplexchallenge
AT radulescumihaela hdvhbvhepatitisreactivationduetoimmunossuppressivetherapyforhematologicalmalignanciesanincreasinglycomplexchallenge
AT nastaseraluca hdvhbvhepatitisreactivationduetoimmunossuppressivetherapyforhematologicalmalignanciesanincreasinglycomplexchallenge
AT morotiruxandra hdvhbvhepatitisreactivationduetoimmunossuppressivetherapyforhematologicalmalignanciesanincreasinglycomplexchallenge
AT poghircviorica hdvhbvhepatitisreactivationduetoimmunossuppressivetherapyforhematologicalmalignanciesanincreasinglycomplexchallenge
AT aramavictoria hdvhbvhepatitisreactivationduetoimmunossuppressivetherapyforhematologicalmalignanciesanincreasinglycomplexchallenge

Ejemplares similares